Idanthra®

Idarubicin

Pick up your armor

Product Information

  • Proprietary Name: Idanthra®
  • Generic Name: Idarubicin
  • Dosage Form: Vial
  • Strengths: 5 mg/5 ml, 10 mg/10 ml, 20 mg/20 ml
  • Indications: Acute Myeloid Leukemia (AML)
Download Leaflet

Oncology

Idanthra®

Idarubicin is indicated for the treatment of acute myeloid leukemia (AML).

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.